The medication works by delivering a fixed daily dose of house dust mite extract, gradually desensitizing the body and alleviating allergic symptoms over time.
Patients are eligible for Acarizax if they experience allergy symptoms more than three days a week for a month and have not responded to traditional treatments.
The National Institute for Health and Care Excellence (NICE) has made a groundbreaking recommendation for Acarizax, a new daily tablet designed for individuals aged 12 to 65 suffering from severe dust mite allergies.
This approval marks the first recommendation for treating moderate to severe house dust mite allergic rhinitis, with NICE estimating that around 13,000 people in England could benefit from this innovative therapy.
Acarizax is intended for a treatment duration of three years and is particularly beneficial for patients who do not find relief from standard treatments such as nasal sprays and antihistamines.
NICE's recommendations emphasize that Acarizax increases the body's resistance to house dust mites, offering a new hope for those affected.
Common symptoms of dust mite allergies, including nasal congestion, sneezing, and itchy eyes, can severely impact daily life, sleep, and mental wellbeing.
Helen Knight from NICE highlighted that Acarizax could significantly improve the quality of life for those with uncontrolled house dust mite allergic rhinitis, enabling them to engage more fully in daily activities.
A pack of 30 Acarizax tablets costs approximately £80, with potential undisclosed discounts negotiated by the health service.
Amena Warner from Allergy UK described the NHS approval of Acarizax as a "landmark step" for individuals with uncontrolled allergies, emphasizing the significant suffering they endure.
While initial treatment requires access to a specialist allergy service, patients can continue their treatment at home, reducing the need for frequent hospital visits.
As the first treatment of its kind, Acarizax represents a significant advancement in addressing severe dust mite allergies in England.
